The properties of cholylsarcosine (the synthetic N-acyl conjugate ofcholic acid with sarcosine IN-methylglycinel) were examined to determine its suitability as a bile acid replacement agent for conditions of bile acid deficiency in the small intestine, which causes fat malabsorption. Previous studies in rodents had shown that the compound was well transported by the liver and ileum and underwent neither deconjugation nor dehydroxylation during enterohepatic cycling. By 'H-nuclear magnetic resonance, cholylsarcosine was found to exist in dilute aqueous solution as an almost equimolar mixture of two geometric isomers-cis and trans (around the amide bond)-in contrast to cholylglycine, which was present entirely in the trans form. The critical micellization concentration was 11 mmol/liter, similar to that of cholylglycine (10 mmol/liter). By nonaqueous titrimetry, the pK; of cholylsarcosine was 3.7, only slightly lower than that of cholylglycine (3.9). 
Introduction
Bile acids function as biological detergents that form mixed micelles with lipids such as fatty acids and monoglycerides, thereby promoting lipid absorption (1) . If the intestinal concentration ofbile acids is below the critical micellar concentration (CMC),' dietary triglyceride is more slowly absorbed and malabsorption of fat-soluble vitamins occurs (1) (2) (3) (4) (5) (6) (7) . Bile acid deficiency occurs when bile acid secretion into the proximal intestine is decreased because of hepatobiliary obstruction or biliary diversion or when active bile acid absorption by the distal ileum is severely impaired. When such conditions induce fat malabsorption, unabsorbed fatty acids pass into the colon and may contribute to diarrhea because of their secretory effects (8, 9) . Therapy for bile acid deficiency due to bile acid malabsorption has included restriction of dietary fat (10) , the administration ofdesiccated animal bile (11) , or the administration of pure bile acids in unconjugated (12, 13) or conjugated (2) form. Low-fat diets are disliked by patients; and desiccated bile preparations may worsen diarrhea, even if they improve steatorrhea (2) . Attempts to use synthetic detergents such as nonionic surfactants have had only modest success (14) (15) (16) (17) (18) .
We reasoned that there was a continuing need for satisfactory bile acid replacement therapy and that the clinical utility ofrestoring bile acids to a concentration well above their CMC had not been given an adequate evaluation because oflack ofa suitable bile acid substitute. Wejudged that a suitable molecule for bile acid replacement would be required to fulfill a number of physicochemical and physiological criteria: (a) it would be insoluble at gastric pH and thus noninjurious to the gastric mucosa; (b) it would dissolve rapidly at small intestinal pH; (c) in the presence of colipase it would not inhibit pancreatic lipase; (d) it would solubilize the products of triglyceride digestion rapidly and efficiently; (e) it (and its bacterial metabolites) would not induce colonic secretion; and (f) it would be inexpensive and well tolerated, since large quantities (up to 10 mmol/meal) would be required iforal supplementation were to replace the normal secretion of bile acids into the small intestine.
A candidate molecule that might fulfill these criteria is cholylsarcosine, the synthetic sarcosine (N-methylglycine) conjugate of cholic acid (Fig. 1) . Previous studies from this laboratory, using rodents, have shown that this compound was well transported by the ileal and hepatic transport systems and underwent neither deconjugation nor dehydroxylation during en- terohepatic cycling (19) . The compound was nontoxic and did not induce changes in biliary lipid composition or liver tests when administered chronically (19) .
In this paper, we have extended our studies on cholylsarcosine to test whether this synthetic conjugated bile acid fulfills the physicochemical and physiological requirements for a satisfactory bile acid replacement for bile acid deficiency states caused by bile acid malabsorption.
Methods

Chemicals
Bile acids. Cholylsarcosine was synthesized in this laboratory from cholic acid (Fluka Chemie AG, Buchs, Switzerland) and sarcosine ethyl ester hydrochloride (Aldrich Chemical Co., Milwaukee, WI) using the method of Tserng et al. (20) . The material was purified by solvent extraction and crystallized in the form of the sodium salt. Chromatographic properties (HPLC and TLC) and structure characterization ('H-nuclear magnetic resonance [NMR] , mass spectrometry) have been reported previously (19) . Additional material of high purity was provided by Diamalt AB, Raubling, FRG (courtesy of A. Vogt, A. Aigner, and T. Messerschmidt). Cholylglycine was prepared in this laboratory by the method ofTserng et al. (20) . Chenodeoxycholic acid was a gift of Diamalt. All bile acids were 2 98% pure by TLC and HPLC. Other chemicals. Human lipase and colipase were prepared and provided by Berit Sternby (Department of Physiological Chemistry, University of Lund, Sweden), who also provided tributyrin (tributyrylglycerol), which was 99.5% pure. Oleic acid (99% pure) and 1-monooleyl-glycerol (99% pure) were purchased from Sigma Chemical Co. (St. Louis, MO) .
Polymeric dyes (Poly R-478 and Poly B-4 11) were purchased from Aldrich Chemical Co. The spectroscopic and physiological properties of these dyes have been reported previously (21 (% = wt/wt% of methanol in solvent mixture) (1) The apparent aqueous solubility of the protonated form of cholylsarcosine and cholylglycine was determined by incubating 20 or 100 ,umol of the bile acid in 4 ml water or saline at room temperature. The pH ofthe water or saline was adjusted to < 2 or 3.0 with an appropriate volume of 1.0 mol/liter HCL. After 3, 7, or 60 d of incubation, a small sample was taken and filtered through a 0.45-gm filter (model HV; Millipore Corp., Bedford, MA). Some samples were centrifuged at 14,000g for 15 min to remove any microcrystals that might have passed through the filter. The bile acid concentration in the samples was determined by HPLC (24) , as well as by enzymatic assay using a 3-hydroxysteroid dehydrogenase assay (25) .
Interaction with calcium. The solubility of the calcium salt of cholylsarcosine was determined according to Jones et al. (26) . Samples of cholylsarcosine or cholylglycine solutions ranging in concentration from 25 to 75 mmol/liter were mixed with 10-75 mmol/liter CaCl2 and 0.15 mol/liter NaCl in a total volume of 4 ml. The samples were thoroughly mixed, incubated at room temperature for I wk, and thereafter centrifuged. The total calcium concentration in the supernatant was determined by a fluorescent dye-binding technique (Calcette model 4009, Precision Systems, Inc., Natick, MA). In addition, in a few experiments the Ca++ activity (ac.++) was determined using an ac.++-specific electrode (Orion Research, Inc., Boston, MA) in the laboratory ofE. W. Moore (Medical College of Virginia, Richmond, VA) (27) . A 3-hydroxysteroid dehydrogenase method was used to determine bile acid concentration ([BA]) in the supernatant (25) . The concentration product (CP) was calculated using the equation CP = [Ca+] * [BA]2, assuming that the insoluble calcium salt had this stoichiometric composition.
In addition, the ac,++ was measured in two samples to give the ion product (IP), which is not very different in value from the solubility product (K5p). The IP was calculated using the equation IP = ac,++ [BA] (26) . Since the bile acid concentration rather than activity was measured, the calculated value for the IP might be slightly higher than the true value for the K5p.
Critical micellization pH (CMpH). The CMpH was measured in a manner similar to that reported by van Berge Henegouwen et al. (28) .
Stepwise increasing amounts of 1 mol/liter HCl were added to a series of bottles containing 25 mmol/liter of a solution of the sodium salt of cholylsarcosine or cholylglycine; the solutions also contained 0.15 mol/ liter NaCl. The samples were incubated for 3 d at 37°C, after which the pH was measured in each sample, using a combination pH calomel electrode and a pH meter (both from Fisher Scientific Co.). The samples were then centrifuged (10,000g for 15 min), and the bile acid concentration in the supernatant was measured, using an endpoint 3-hydroxysteroid dehydrogenase-based assay (Sigma Chemical Co.), as described by Turley and Dietschy (25) . The bile acid concentration (ordinate) was plotted against pH, and a vertical line was drawn through the vertical part ofthe curve toward the x-axis. The intercept of this line with the abscissa was defined as the "CMpH."
The CMCs of the sodium salts of cholylsarcosine, cholylglycine, cholyltaurine, and cholic acid were determined using a dynamic surface tension device based on the maximum bubble pressure method. The device, which was designed by K. J. Mysels, has been described in detail (29, 30) ; and the method has been fully validated (31) . It has been used previously by this laboratory to measure the CMC of bile acids (31) . For the present studies, bile acids were repurified by column chromatography to an HPLC purity exceeding 99%, and great care was taken to keep all surfaces uncontaminated by surface-active impurities. The surface tension was measured at different concentrations at bubble intervals of 1 and 2 s. The surface tension (ordinate) was plotted against the logarithm of the bile acid concentration. This gave two lines: one above the CMC, which showed little change in surface tension with increasing concentration, and one below the CMC, which showed a near-linear concentration-dependent decrease in surface tension. The linear regressions of the two lines were calculated using the method of least squares and the intersection of the two lines was taken as the CMC. For bile acids tested, the difference in CMC between two bubble intervals (I and 2 s) was < 5%; accordingly, all bile acids were considered to be uncontaminated significantly by surface-active impurities. All measurements were done with a total Na' concentration of 0.15 mol/liter. The surface pressure (i.e., the decrease in surface tension) at I mmol/liter and at the CMC was calculated by subtracting the measured surface tension at 1 mmol/liter and at the CMC from the surface tension of water at 370C (70.1 dyn/cm).
CMC of cholylsarcosine in the presence of (1) Micellar solubilization ofa fatty acid and monoglyceride mixture. Equimolar amounts of oleic acid, oleate, and monoolein (termed an oleyl mixture) were mixed with different proportions of bile acid to make a total substance concentration of 20 mmol/liter (cf. reference 34) . After overnight incubation, the turbidity (indicated by absorbance at 400 nm) was measured using a spectrophotometer (Uvikon model 860, Kontron Instruments, Milan, Italy).
In vitro lipolysis. The effect of cholylsarcosine, cholylglycine, cholyltaurine, or deoxycholyltaurine on the activity ofpure human pancreatic lipase/colipase, carboxyl ester lipase, as well as on the lipolytic activity present in aspirated human pancreatic juice, was determined using the assay system described by Erlanson and Borgstrom (35) . Samples were acquired at the Lund University Hospital some years ago from patients without pancreatic disease; informed consent was obtained. The substrate consisted of 0.5 ml tributyryl-glycerol that was emulsified in 10 ml buffer (consisting of 1 mmol/liter Tris-maleate, 1 mmol/liter CaCl2, and 0.15 mol/liter NaCl at pH 7.0). Hydrolysis was induced by the addition of the following: (a) 25 Ml lipase (100 Mg/ml) and 5 ul colipase (100 ,ug/ml), (b) 50 ul cholesterol ester lipase (1 mg/ ml), or (c) 10 ,l pancreatic juice. The bile acid concentration was 4.0 mmol/liter, except for lipase/colipase, where 10 mmol/liter also was tested. The assay was performed at room temperature; for lipase/colipase, the assay was also performed at 37°C. A video titrator (model VIT 90; Radiometer, Copenhagen, Denmark) was used to measure the rate of fatty acid release. The last 2 min of a 5-min incubation were used to calculate the activity of the enzymes, which was expressed as gkatal/mg protein (katal = amount ofenzyme activity that transforms 1 mol/s of substrate). The activity of pancreatic juice was expressed in percentage ofcholylsarcosine rather than gkatal/mg protein, since pancreatic juice contains multiple lipolytic enzymes.
Physiological experiments
Triolein absorption in lymphfistula rats. These experiments were done in the laboratory of B. Borgstrom (Dept. of Physiological Chemistry, University of Lund, Sweden) using a technique developed by Tso et al. (36) . Sprague-Dawley rats (ALAB, Sodertilje, Sweden), weighing 230-240 g, were fasted overnight, anesthetized with ether, and a midline abdominal incision was made. A segment of vinyl tubing (Dural Plastics and Engineering, Dural, Australia, 0.5 mm i.d.), with a PP-l0 (Portex) tip, was inserted in the proximal biliary duct, and the thoracic duct was cannulated using identical tubing. Another segment of tubing was passed through the stomach wall and the tip positioned 30mm into the duodenum. The animals were housed at 30C in Bollman restraining cages; chow was withheld but water was allowed ad lib. A solution of 140 mmol/liter glucose, 85 mmol/liter NaCl, and 6.7 mmol/liter KCl was infused overnight into the intestine in order for the animals to recover from surgery and stabilize the lymph flow. The following morning a fat emulsion consisting of 5 mmol/liter triolein, [3H]triolein (0.17 MBq), 1 mmol/liter phosphatidylcholine, and 15 mmol/liter of cholylsarcosine orcholyltaurine was infused. Cholyltaurine was used as a control in this study, since it is more commonly used in this type of experiment. The fat was emulsified in the glucose solution described above with the help of ultrasound. The emulsion with one of the bile acids was infused at a rate of 3.0 ml/h over 8 h the day after surgery. The other bile acid was infused the following day. Lymph and bile were collected in 1-h aliquots for 20 h. Since the emulsions were not completely stable and emulsion droplets collected at the top of the tube, a sample of the fat emulsion was taken at the beginning and end of the infusion to correct for a decrease in the concentration of dispersed triglyceride droplets. Although this is an experimental problem, the results still allow a comparison of the two bile acids.
For analysis, lymph flow was measured gravimetrically and radioactivity was measured in 0.5 ml of lymph. Scintillation cocktail (10 ml) was added and the samples were counted in a liquid scintillation counter.
Perfusion ofrabbit colon with bile acid solutions. A technique previously described by Chadwick et al. (37) was used. Male New Zealand rabbits (Holbert's Rabbitry, Spring Valley, CA), weighing 1.45-1.75 kg, were housed in the animal quarters 2 1 wk before use. The animals were anesthetized intraperitoneally with ketamine after an overnight fast, and a midline abdominal incision was made. A PE-160 catheter was inserted through the cecal wall and pushed 1 cm into the colon. The tubing was secured with a purse-string suture in the cecal wall, and the colon was tied loosely around the tubing as it entered the colon. The entire colon was rinsed with 100-150 ml saline at 37°C or until the effluent was clear. To collect effluents, a 24-Fr Foley silicone catheter was inserted 3 cm into the rectum and the balloon inflated. Body temperature was maintained at 38±0.5°C with a heating lamp connected to a temperature probe. Before bile acid perfusion, the colon was perfused at a rate of 1.3 ml/min for 60 min with a perfusion solution prepared to simulate colonic contents (120 mmol/liter NaCl, 5 mmol/ liter KCl, and 25 mmol/liter NaHCO3, pH 8.0). The perfusate was preheated to a temperature of 38°C. A nonabsorbable polymeric dye marker, Poly-R or Poly-B, was added to quantify water absorption/secretion (21) and ['4C]erythritol (18 kBq, together with I mmol/liter erythritol as carrier), was added to allow assessment ofepithelial permeability. Each animal was perfused for 60 min with 5 mmol/liter of cholylsarcosine, cholyltaurine, or chenodeoxycholate perfusion solution. Either cholylsarcosine or cholyltaurine was perfused afterthe control period, whereas chenodeoxycholate always was perfused as the last bile acid since it is known to be cytotoxic, and the changes induced might not be rapidly reversible. 10-min aliquots ofthe colonic effluent were taken during the entire experiment.
Examination ofthe effluent by TLC showed that it took 20-40 min to completely replace one bile acid by the following one (38) . Accordingly, the fourth to the sixth collection period and the first ofthe following collection period were considered to represent steady-state intervals for water secretion/absorption and erythritol loss determination.
For analysis of radioactivity, 500 1l of each aliquot was pipetted into a scintillation vial and 10 ml of Scinti-Verse BD (Fisher Scientific Co.) was added. For analysis ofabsorbance, 2 ml was taken offand used for determination of the absorbance at 520 nm (Poly-R) or 595 nm (Poly-B) in a spectrophotometer (Gilford, Instrument Laboratories, Inc., Oberlin, OH). Calculations were done as follows. Water absorption/secretion was calculated using Eq. 2:
where AW is absorption in ml/U, F is perfusate flow in ml/h, OD, is optical density of sample, and OD. is optical density of unused perfusate. Percent loss of ['4C]erythritol was calculated using Eq. 3:
where L is loss of [ 
Results
Physicochemical properties
The 'H-NMR spectrum ofthe acid form in d6-dimethylsulfoxide (Table I) showed a trans/cis ratio of 3, that is, 75% of the compound was present as the trans conformer. This behavior parallels that of a simpler model compound, acetylsarcosine, where 70% is in trans form for the acid form and 48% is in the trans form when the anion is present (39) . The 'H-NMR spectrum of the sodium salt of cholylsarcosine in deuterated water at a concentration below the CMC (3 mmol/liter) ( Fig. 2a and Table I ) showed two sets of peaks for many hydrogens. This is in sharp contrast to the 'H-NMR spectra of glycine or taurine (40) conjugates ofbile acids, where only one resonance is found for each type of hydrogen. A typical example, the 'H-NMR spectrum of the sodium salt of cholylglycine, under the same conditions is presented in Fig. 2 b, and Table I . The two sets of peaks in the case of cholylsarcosine are due to the presence of two isomers, trans and cis (see Fig. 9 ), by rotation around the amide bond. The two isomers interconvert slowly on the NMR time scale and are therefore observed as two sets of resonances. The assignment of the trans and cis resonances for the Nmethyl group and the a-CH2 group of glycine was based on well-known chemical shift differences for groups E or Z to the amide carbonyl (41) . Cholylglycine presents only one set of resonances, which can be safely attributed to the almost exclusive presence ofthe trans isomer. It has been found that amides with one alkyl substituent on the nitrogen atom exist in solution preponderantly in the trans form; in most cases, the cis form is not detectable (39, 41) .
The cholylsarcosine trans/cis ratio in water was 0.83 and was not altered at 15 mmol/liter (above CMC) or in the presence of 0.15 M NaCl. (The spectra were essentially identical to Fig. 2a and are not shown.) Acidity constant. The pH# measured when 50% of the acid had been titrated was plotted against mole fraction of organic solvent for each of the bile acids as well as for acetic acid (Fig.  3) , and the regression line was calculated for the three points.
The pK. calculated from the regression lines were 3.7 for cholylsarcosine and 3.9 for cholylglycine. Thus, cholylsarcosine is a stronger acid than cholylglycine, its pKa being 0.2 pKa units lowerthan that ofcholylglycine. The pKa ofacetic acid was also measured by this technique, and the expected value of 4.8 was obtained.
The apparent aqueous solubility ofthe protonated form for cholylsarcosine was 2.4±0.0 mmol/liter and that of cholylglycine 0.6±0.0 mmol/liter when incubated for 60 d in 0. 15 mol/ liter NaCl at a pH < 2 with 25 ,mol bile acid per ml solution.
In incubations set at pH 3, a slightly higher solubility ofthe bile acids was measured: cholylsarcosine, 3. 1±0.0 mmol/liter and cholylglycine, 0.7+0.0 mmol/liter. The higher solubility at this pH is explained by the additional presence of cholylsarcosine anions. Cholylsarcosine, having a lower pKa than cholylglycine, will display a greater increase in solubility at this pH. Determination of the bile acid concentration with 3-hydroxysteroid dehydrogenase confirmed the HPLC results.
Interaction with calcium and solubility ofthe calcium salt. Table II shows the concentration of cholylsarcosine, cholylgly- Figure 3 . Determination of the acidity constant (pKI) by plotting the pH# measured when 50% of the acid was titrated against mole fraction of organic solvent. The regression line was calculated for the three points and the pK, determined by extrapolation to a mole fraction of zero.
cine, and CaCl2 in the incubations, whether a precipitate was formed, the concentration product ofthe bile acid and Ca++ in the supernatant, and the ion product based on measurement of ac,++ and bile acid concentration in the supernatant. Precipitates occurred with cholylsarcosine only at a concentration of 10 mmol/liter CaCl2 and did not occur with cholylglycine. The solubility product for cholylglycine could not be obtained in these experiments since it did not precipitate from solution; solutions of cholylglycine that are supersaturated with respect to the calcium salt are known to manifest remarkable metastability (26) . Thus, although the solubility product ofcalcium salt of cholylsarcosine is quite high, its supersaturated solutions, in contrast to those of cholylglycine, do not inhibit metastability. The incubations were in 0.15 mol/liter NaCl, which will decrease the activity coefficient of cholylsarcosine. Thus, the calculated IP of 1.8±0.4 X I0O-(mol/liter)3 for cholylsarcosine is approximately twice the true value of the Ksp which is -I X IO-7 (mol/liter)3.
CMpH. Fig. 4 illustrates the bile acid concentration in supernatant in relation to final supernatant pH. The bile acid concentration increased very sharply over a narrow pH range, which indicates the CMpH. The CMpH value for cholylsarcosine was 3.7, a value considerably lower than that of cholylglycine, which was 4.8.
The CMCs for the sodium salts of cholylsarcosine, cholylglycine, cholyltaurine, and cholic acid ranged from 9 to 11 mmol/liter, respectively, indicating that all three cholic acid conjugates had a CMC similar to that ofthe unconjugated bile acid sodium cholate (Table III) . The surface activity, as evidenced by the decrease in surface tension with increasing concentration, was similar for all cholic acid conjugates. Typical curves for cholylsarcosine and cholylglycine are shown in Fig. 5 .
CMC ofcholylsarcosine in thepresence ofl -monooleyl glycerol. Fig. 6 shows the maximum solubility of (1 ) Table IV . There was only a slightly lower solubilization capacity for cholylsarcosine at a ratio of 3:2 oleyl additives/bile acid.
In vitro lipolysis. The concentration product was calculated from the Ca"+ ion concentration and bile acid concentration in the supernatant of the incubations. The value for the ion product was based on Ca`+ activity rather than concentration and should give a value about twice that of the true solubility product. The approximate solubility product for the calcium salt of chenodeoxycholylglycine is 0.2 X 10-7; that of ursodeoxycholylglycine is 0.4 x 10-7, and that of cholylglycine is -6 x 10-7 (mol/liter)3 (32). Physiological properties Triolein absorption in lymphfistula rats. The total recovery of infused [3H]triolein (15 ,tmol/h) in lymph was 52±10% for cholylsarcosine and 52±11% for cholylglycine. There was no significant difference between the two bile acids. Fig. 7 40 ,Lmol/h triolein was infused in the rat. This dose is closer to the normal fat intake of the rat.)
Effect ofcholylsarcosine on water movement in the perfused rabbit colon. Fig. 8 , top, indicates that cholylsarcosine did not induce colonic secretion; nor did cholylglycine at a concentration of 5.0 mmol/liter. In contrast, when chenodeoxycholate (Fig. 9 ). Both isomers interconvert easily at room temperature by rotation around the amide C -N bond, but the trans conformer appears to be the only one found in water solutions of common bile acids (Fig. 2 b) (40) . The significant steric interference between the 23-methylene group and the methylene group ofglycine (or j3 methylene oftaurine) present in the cis isomer makes this conformer less stable than the trans isomer, where the 23-methylene group is close to the sterically less demanding hydrogen atom. In NN-dialkyl amides, both isomers are generally present in solution in proportions that depend on the relative free energy of the two isomers (41) . Sarcosine conjugates have two groups of similar size on the nitrogen atom: the methylene group of glycine and the N-methyl group; the cis (glycine close to side chain) and trans (N-methyl close to side chain) isomers have, therefore, similar energies (Fig. 9) . Accordingly, the water solution of the sodium salt of cholylsarcosine contained a 0.83:1 mixture of the trans and cis isomers (Table I) .
Although the rate ofinterconversion is fast at room temperature, the presence of a significant proportion of cis isomer provides an explanation for sarcosine conjugates possessing physicochemical properties slightly different from those of natural bile acids. The pK. of cholylsarcosine provides an example: cholylsarcosine is slightly more acidic (PKa 3.7) than cholylglycine (pKa 3.91). This difference also parallels that of the model compounds acetylsarcosine, PKa 3.34 (calculated from reference 39), and acetylglycine, pKa 3.67 (42) . Evans and Rabenstein (39) found that the trans conformer ofacetylsarcosine is less acidic (PKa 3.5) than the cis conformer (pKa 3.1). The evidence seems to indicate that in the trans form the acidic proton forms an intramolecular hydrogen bond with the amide carbonyl ( Fig. 10) , whereas in the cis form this is not possible. This renders the trans conformer of the protonated acid more stable, thus decreasing its acidity compared with the cis isomer.
In accordance with these observations, the 'H-NMR spectra of both cholylsarcosine (Fig. 1) and acetylsarcosine (39) showed a high trans/cis ratio (3 and 2.3, respectively) for the acid forms; and acetylglycine, which should exist almost exclusively in the trans form, has a pKa (3.67) very close to the trans conformer (3.5) of acetylsarcosine. Our pKa and 'H-NMR measurements suggest that this description can be safely extended to the cholylsarcosine case. Thus, the presence of a substantial proportion of the more acidic cis conformer in sarcosine conjugates will contribute to an increase in the overall macroscopic acidity constant compared with all trans glycine conjugates.
The rather high apparent aqueous solubility of the protonated form of cholylsarcosine was quite unexpected. The protonated form of cholylsarcosine forms a hydrated gum in water, which may promote aqueous solubility or may have led to contamination ofthe aqueous phase by hydrated microcrystals that were not removed by filtration or centrifugation; in contrast, cholylglycine remains present as discrete crystals. 
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The assay was performed at pH 7.0. Statistical difference relative to cholylsarcosine is indicated by: * P < 0.05; $ P < 0.01; § P < 0.001. [4] [5] during digestion (48) . Thus, cholylsarcosine might cause gastric irritation since it is soluble at a pH > 3.7.
Solubilization ofthe oleyl mixture was very similar for cholylsarcosine and cholylglycine. Cholylsarcosine differed from cholylglycine in having a slightly lower solubility product of its calcium salt. Nonetheless, the K5p of the calcium salt of cholylsarcosine was one to two orders of magnitude higher than the corresponding calcium salts of deoxycholylglycine or chenodeoxycholylglycine (26) . Accordingly, formation ofthe calcium salt in the gallbladder is unlikely, since the ionized calcium concentration in gallbladder bile is usually < 2 mmol/liter (43) and the monomeric concentration of cholylsarcosine will be in the range of 1-2 mmol/liter (44) .
Micellar aggregation. The CMpH was considerably lower for cholylsarcosine than for cholylglycine. Probably two factors are responsible. The first is the greater solubility ofthe protonated form of cholylsarcosine at low pH. When the protonated species is more soluble, there is a corresponding increase in the concentration of the ionized species at acidic pH. As the pH is increased, there is an exponential increase in the concentration of the ionized form; and when it reaches the CMC (at the CMpH), micelles are formed. A higher concentration of protonated species may promote the formation of mixed micelles containing both species at a lower bulk pH. A second factor contributing to the lower CMpH of cholylsarcosine is the slightly lower pKa of cholylsarcosine, resulting in greater ionization of cholylsarcosine for a given bulk pH.
The CMC of cholylsarcosine was very close to its glycine and taurine congeners, which implies that it will form mixed micelles in the jejunum. The average concentration of bile acids in the human jejunum is 5-10 mmol/liter (6) , which is about the CMC ofcholylsarcosine. However, the CMC for cholylsarcosine in the presence of a C18 1-monoglyceride was 5 mmol/liter, which indicates that mixed micelles form, well below the CMC ofcholylsarcosine alone. Whether a bile acid will form mixed micelles below its CMC in vivo will depend on its interaction with other biological amphiphilic molecules such as monoolein, oleic acid, and phosphatidylcholine, which all *are present in jejunum during digestion (32, 44, 45) . The measured CMC for cholylglycine in the presence of a C,8 1-mono- glyceride was in good agreement with literature data (33) . pancreatic lipolytic activity.
Physiological properties
The results from the intestinal perfusion studies in lymph fistula rats indicated that cholylsarcosine functions as well as cholyltaurine as an enhancer oftriolein absorption in this particular animal model. The steady-state lymphatic output of65% of the triglyceride infused (Fig. 7) during triolein/cholylsarcosine administration was similar to results from other investigators using the same experimental model (49) . Incomplete recovery may indicate incomplete collection ofabdominal lymph, incorporation of fatty acid into enterocyte membrane lipids, or Cholylsarcosine and cholyltaurine did not cause any colonic secretion, in contrast to chenodeoxycholate which was a potent secretagogue. The lack of secretory effect of cholyl conjugates is in agreement with several other studies in both human (51) and rabbit (37, 52) in which endogenous bile acids have been perfused. In addition to cholyl conjugates, hydrophilic trihydroxy-and tri-oxo bile acids-as well as hydrophilic dihydroxy bile acids such as ursodeoxycholate-do not induce secretion by the colon, at least not at concentrations < 10 mmol/liter. In contrast, lipophilic dihydroxy bile acids, such as deoxycholate or chenodeoxycholate, evoke secretion of water in the colon at concentrations above the CMC (-3 mmol/ liter).
Clinical implications
Cholylsarcosine is potentially useful as an exogenous surfactant to promote micelle formation in patients with resection of most of the terminal ileum or with an external biliary fistula. Such patients are likely to require a large amount of cholylsarcosine, 4-6 g/meal, since there is a greatly impaired enterohepatic circulation in such patients and orally administered cholylsarcosine will not be actively absorbed. Cholylsarcosine is not absorbed passively from the small or large intestine because of its low pKa and its resistance to bacterial deconjugation and dehydroxylation (19) .
Cholylsarcosine might also be useful to enhance cyclosporin absorption in liver transplant patients in whom bile is diverted for up to 1 wk after transplantation. Absorption of where the asterisks denote values in the particular methanol/water composition, pH* is the pH referred to standard solutions in the same solvent system, and y-y is the activity coefficient of the anion in the solvent mixture. Since the activity coefficient ofthe ionized bile acid is close to 1 at the low ionic strength used, and the correction for hydrolysis is small (55) , pK* can be approximated to pH*,2 at one-half neutralization ([A-]/[AH] = 1).
The measurement of pH* requires that the glass electrode/pH meter be calibrated with standard solutions in the particular water/ methanol mixture used. Although these buffers have been described (56) , they are not necessary ifwhat is desired is a value calculated from extrapolation to zero organic solvent concentration. If the pH meter is instead calibrated with standard aqueous solutions, the measurement carried out in a solvent mixture will give pH#, different from pH*. However, the difference between pH# and pH* is an approximately linear function ofthe methanol concentration and extrapolates to zero for pure water (56) . With the electrode calibrated with aqueous solutions, for a particular solvent mixture, at one-half neutralization, we obtain: pKa = pHI#/2 where pK,# is a "mixed" constant that includes pK* and the difference between pH# and pH* for that particular solvent mixture. Since the relationships between both quantities and methanol concentration are linear, and the pH difference extrapolates to zero for pure water, we conclude that pK: extrapolates to PKa. However, the plot of pK: versus molar fraction of methanol will have a slope different from the one obtained from pH* measurements. To test its suitability, we determined the PKa ofacetic acid by this method. We obtained a good linear correlation between pKa and the molar fraction of methanol (r = 0.999) and an extrapolated PKa in excellent agreement with the reported value (23).
